Clinical mixed preparation for cardiovascular department and preparation method

Abstract

The invention discloses a clinical mixed preparation for a cardiovascular department and a preparation method, and belongs to the field of traditional Chinese medicine. The effective component of the clinical mixed preparation is prepared through the steps that radix angelica sinensis, ligusticum wallichii, safflower carthamus, salvia miltiorrhiza, American ginseng, panax notoginseng, cortex moutan radicis, lumbricus, leeches and gadflies are decocted and then filtered, zygosaccharomyces bailii is added in obtained filtrate and medicine dregs, and the zygosaccharomyces bailii is cultured for 168-240 hours in a standing mode in a corresponding temperature and humidity environment to obtain oral liquid or orally-taken tablets or capsules. The clinical mixed preparation mainly treats heart and cerebral vusculer diseases, hypertension and blood diseases, is directly and orally taken and is capable of quickly achieving the effects, free of relapse, rapid to absorb, high in treating effect and sweet in taste, and no sequela or complication occurs after the clinical mixed preparation is taken; two special technologies of solid fermentation and liquid fermentation are achieved in the traditional Chinese medicine through microorganism application, the toxic and side effects of the raw material medicine are removed, storing and eating are convenient, and no waste medicine dreg is generated. The clinical mixed preparation is rich in raw material source, easy to prepare, low in cost, capable of achieving both treatment and health care and suitable for treating, rehabilitating and nursing of cardiovascular department diseases.

Description

Technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a compound preparation used in clinical cardiovascular medicine and a preparation method thereof. Background technique [0002] At present, about 3 million people die of cardiovascular disease in China every year, accounting for 40% of all causes of death. It is the number one killer of Chinese residents. Research predicts that the incidence of stroke among middle-aged men in China will increase by 42% in the next 10 years Women will increase by 13%, and the incidence of coronary heart disease will increase by 26% for men and 19% for women. In 2003, the direct medical cost of heart disease in China was 130.117 billion yuan, accounting for the proportion of China's total medical expenses and total health expenses in the same period. 22.65% and 19.74%; the top three diseases were hypertension (36.603 billion yuan), coronary heart disease (26.433 billion yuan), ...

AI Technical Summary

Problems solved by technology

[0005] Apply microbial traditional Chinese medicine fermentation technology to the traditional Chinese medicine formula for the treatment of cardiovascular and cerebrovascular diseases, and create a product with fast absorption, high curative effect, quick effect, no repetition, low price, sweet taste, easy storage, convenient consumption, and no sequelae or complications after taking it. The finished product of traditional Chinese medicine has not yet been seen